Taking people in Németország1. fázis
A Phase 1 Study of the Safety and Preliminary Efficacy of CTX112 in Adult Subjects With Refractory Autoimmune Disease.
Key facts
- Where
- Augsburg, Cologne, Frankfurt Am Main, Hanover és Mainz, NémetországSee the 5 sites
- Phase
- 1. fázis
Where in Németország
- Universitaetsklinikum AugsburgAugsburg, NémetországTaking people
- University Hospital Cologne AöRCologne, NémetországTaking people
- Fraunhofer Institute For Translational Medicine And Pharmacology ITMPFrankfurt Am Main, NémetországTaking people
- Medizinische Hochschule HannoverHanover, NémetországTaking people
- Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöRMainz, NémetországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- CRISPR Therapeutics AG
- Trial code
- EU 2024-518528-54-00
- Record updated
- 2026. augusztus 17.